Early research (Phase 1)Study completedNCT00004047What this trial is testingChemotherapy in Treating Patients Who Have Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508What this trial is testingStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromWho this might be right forWaldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT06561425What this trial is testingA Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell Lakefront Biotherapeutics NV 130
Testing effectiveness (Phase 2)Study completedNCT01261247What this trial is testingPanobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more Mayo Clinic 41
Not applicableStudy completedNCT03582098What this trial is testingClinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and IrelandWho this might be right forChronic Lymphocytic Leukaemia Gilead Sciences 112
Testing effectiveness (Phase 2)Study completedNCT01105247What this trial is testingSafety of PCI-32765 in Chronic Lymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Pharmacyclics LLC. 133
Testing effectiveness (Phase 2)Study completedNCT00918333What this trial is testingPanobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more Mayo Clinic 124
Large-scale testing (Phase 3)Study completedNCT02801578What this trial is testingDifferent Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 11
Early research (Phase 1)Not Yet RecruitingNCT07511426What this trial is testingU96-CAR-T-Cells For R/R B-ALLWho this might be right forRelapsed or Refractory B Cell Leukemia and Lymphoma The First Affiliated Hospital of Soochow University 30
Early research (Phase 1)Enrolling By InvitationNCT06788509What this trial is testingA Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin+4 more Janssen Research & Development, LLC 120
Testing effectiveness (Phase 2)Ended earlyNCT02701517What this trial is testingCyclosporine Plus Methotrexate or AlemtuzumabWho this might be right forUnrecognized Condition: Mature B or T-cell Neoplasm Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 72
Testing effectiveness (Phase 2)Ended earlyNCT02742090What this trial is testingEvaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior TherapyWho this might be right forChronic Lymphocytic Leukemia TG Therapeutics, Inc. 51
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Early research (Phase 1)Study completedNCT00002818What this trial is testingHigh-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Study completedNCT00072007What this trial is testingCladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLWho this might be right forLeukemia Swiss Cancer Institute 43
Testing effectiveness (Phase 2)Study completedNCT00002809What this trial is testingBone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Temple University 10
Testing effectiveness (Phase 2)Study completedNCT02793544What this trial is testingHLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation CyclophosphamideWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more Center for International Blood and Marrow Transplant Research 80
Early research (Phase 1)Ended earlyNCT00003567What this trial is testingGene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00962507What this trial is testingPanobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm City of Hope Medical Center 11